Skip to main content

Advertisement

SpringerLink
Log in

Aggressive skin cancer in chronic GvHD after allogeneic hematopoietic cell transplantation

  • Letter to the Editor
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2

References

  1. Zampaolo AS, Kanold J, Tournilhac O, Franck F, Bachelierie M, D’Incan M . Aggressive skin cancers in patients who experienced chronic GvHD after allogeneic bone marrow transplantation. Bone Marrow Transplant (e-pub ahead of print 18 July 2016; doi:10.1038/bmt.2016.187).

    Article  Google Scholar 

  2. DePry JL, Vyas R, Lazarus HM, Caimi PF, Gerstenblith MR, Bordeaux JS . Cutaneous malignant neoplasms in hematopoietic cell transplant recipients: a systematic review. JAMA Dermatol 2015; 151: 775–782.

    Article  Google Scholar 

  3. Leisenring W, Friedman DL, Flowers ME, Schwartz JL, Deeg HJ . Nonmelanoma skin and mucosal cancers after hematopoietic cell transplantation. J Clin Oncol 2006; 24: 1119–1126.

    Article  Google Scholar 

  4. Omland SH, Gniadecki R, Hædersdal M, Helweg-Larsen J, Omland LH . Skin cancer risk in hematopoietic stem-cell transplant recipients compared with background population and renal transplant recipients: a population-based cohort study. JAMA Dermatol 2016; 152: 177–183.

    Article  Google Scholar 

  5. Inamoto Y, Shah NN, Savani BN, Shaw BE, Abraham AA, Ahmed IA et al. Secondary solid cancer screening following hematopoietic cell transplantation. Bone Marrow Transplant 2015; 50: 1013–1023.

    Article  CAS  Google Scholar 

  6. Wojenski DJ, Bartoo GT, Merten JA, Dierkhising RA, Barajas MR, El-Azhary RA et al. Voriconazole exposure and the risk of cutaneous squamous cell carcinoma in allogeneic hematopoietic stem cell transplant patients. Transpl Infect Dis 2015; 17: 250–258.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Mayo Clinic, Rochester, MN, USA

    J S Lehman & C L Baum

  2. Department of Otorhinolaryngology, Mayo Clinic, Rochester, MN, USA

    E Moore & D Price

  3. Department of Laboratory Medicine and Pathology, Mayo School of Graduate Medical Education, Rochester, MN, USA

    S Toosi

  4. Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA

    S K Hashmi

Authors
  1. J S Lehman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C L Baum
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E Moore
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D Price
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S Toosi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S K Hashmi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J S Lehman.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lehman, J., Baum, C., Moore, E. et al. Aggressive skin cancer in chronic GvHD after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 52, 457–458 (2017). https://doi.org/10.1038/bmt.2016.290

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2016.290

  • Springer Nature Limited

Search

Navigation